ARCHIVES

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

Advisors Suggest Consortia For Lung Cancer Research.

November 9, 2001

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

In Brief: NCI Gets $937 Million For FY 79 As Congress Adjourns; Cancer Act Renewed For Two Years

October 20, 1978

CCRAC Cool to Three Psychosocial Proposals, Approves One On Aging

October 26, 1979

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010